Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Arecor has announced its partner, Inhibrx, has exercised an option to license a novel enhanced formulation of Inhibrx's proprietary therapeutic candidate, INBRX-101, developed by Arecor.
read more
Amgen announced the FDA has approved RIABNI, a biosimilar to Rituxan.
read more
Thermo Fisher Scientific has announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif.
read more
Sygnature Discovery is strengthening its HTS and translational oncology service-offerings by investing £3 million in new instrumentation and equipment.
read more
Wednesday, December 30, 2020
Samsung Biologics announced John Rim as its President and CEO.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Wednesday, December 30, 2020
Lipidor announced the Company has signed a new cooperation agreement with Aurena Laboratories AB.
read more
Wednesday, December 30, 2020
Cerner announced an agreement to acquire Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment.
read more
Wednesday, December 30, 2020
Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship.
read more
Wednesday, December 30, 2020
Relaxera Pharmazeutische Gesellschaft mbH & Co. KG and CBL Patras announce the signing of an exclusive contract for human relaxin-2.
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more
Tuesday, December 29, 2020
Immutep has prioritized the recommencement of the process of scaling up the manufacturing of its lead product candidate eftilagimod alpha.
read more
Tuesday, December 29, 2020
Harbour BioMed and Utrecht University announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Monday, December 28, 2020
Gattefossé is investing 30 million euros in its industrial operations and announces the construction of a new manufacturing plant in Lufkin, Texas.
read more